App-Quantinova.ai

Decision-making in the older patient with diagnosis of cancer: Sarcopenia and frailty as predictors of toxicity to chemotherapyONCOSARCO project.

Carmen Guillen - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Chemotherapy (CT) for advanced soft tissue sarcoma (STS) in older patients (pts): Toxicity and outcomes in a single center experience.

Antonella Brunello - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Solid malignancies

N/A

Quality of life and relationship with early lethality of elderly patients with cancer.

Jurema Telles O Lima - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filgrastim prophylaxis in elderly cancer patients: A French multicenter observational study (TULIP).

Ivan Krakowski - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Filgrastim

Frailty and health-related quality of life (HRQOL) in older women with breast cancer (BC).

Grant Richard Williams - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Factors associated with intention to participate in a randomized yoga intervention among African American breast cancer survivors.

Sri Lakshmi Yeruva - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Assessment of distress in primary caregivers of patients with advanced cancer.

Iris Gluck - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Characteristics of the Suscro Distress Inventory (SDI) for cancer survivors.

Matthew Francis Hudson - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Psychosocial care needs for pediatric cancer patients and their families in Ibadan, Nigeria: perspective from experience with patients on the ward.

Elizabeth Oluwatoyin Akin-Odanye - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Association between Beck depression inventory, Montgomery-Asberg depression rating scale and genotypes of the CYP17 steroid metabolism gene in breast cancer.

Riika Susanna Korhonen - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Cataloguing depression among cancer patients by stage and source of malignancy.

Uri Goldberg - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The awareness of depression and anxiety in cancer patients.

Yu-qing Wang - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Developing and evaluating new models of care in hematology.

Jonathan Sussman - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Assessment of concerns and distress during the survivorship summary of care plan appointment.

Patricia A. Robinson - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A retrospective review of patient-reported understanding of survivorship care plans.

Natalie Garces - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Surveillance of cancer survivors: Results from a survey of primary care physicians working in the Spanish National Health System.

Begona Grana - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

An observational cohort study on terminal cancer survivors practicing falun gong (FLG) in China.

Yuhong Dong - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Evaluation of chemotherapy tolerability for breast cancer patients who have received radiation as treatment for a prior Hodgkin lymphoma.

Allison Paige Watson - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Lifestyle issues affecting health and well-being of BRCA mutation carriers.

Aileen Caceres - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Patient reported outcomes in acute inpatient rehabilitation in a comprehensive cancer center.

Amy Ng - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filters

41730 Abstracts